December 8, 2011 – OmniVision, a developer of advanced digital imaging solutions, announced that its ultra-compact, high-performance OV6930 CMOS image sensor performed exceptionally well in a recent 448-patient clinical study on Avantis Medical Systems' Third Eye Retroscope. The study, published in the March issue of Gastrointestinal Endoscopy, demonstrates that the Third Eye Retroscope can increase the accuracy in diagnosing adenomas, or pre-cancerous polyps, by 23.2 percent when used in conjunction with a traditional colonoscope..... Look at OVTI trading $ 11.79 has $ $8 cash on hand per share and will earn $ 1.25 per share ( Iphone Camera ) Look at the Money FLOW Very Positive. Image sensor growth is confirmed, where revenue is expected to grow by more than 15% in 2011, iSuppli reported. OVTI $11.79 PE 4.5 PEG.52 Price to sales .71 and has $ 8 cash on hand per share OVTI could easily be a take out target 3 times cash on hand and 1200 patents $27 my price target.
OVTI management recently started a 100 million Dollar buy back.
Why so many rumors ipad3newsblog.com/2011/12/ipad-3-rumor-round-up/
The iPad 2 camera was full of false hope, as owners weren’t very happy with the quality and feel considering the high end device they had purchased. The iPad 3 camera is reportedly being handled by Omnivision Technologies Inc. and will be coming in at 5MP fashion. The OV5690 by Omnivision was developed with tablets and smartphones in mind, considering its support to the ever thinning of devices. The OV5690 will reduce the camera module height by a lovely 20 percent and likely bring to the table full 1080P capabilities.